Among the demands that President Trump has made to the pharmaceutical industry to lower drug prices, there’s been one that companies have enthusiastically supported: selling drugs directly to consumers. Even before Trump began discussing the idea, Eli Lilly and Novo Nordisk had adopted this model for their blockbuster weight loss treatments — offering discounted cash prices to patients not using …
Read More »Pharma is pivoting to expand direct-to-consumer sales. Will prices come down?
